Liquid%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520paraffin

# Liquid Paraffin ## Overview Liquid paraffin, also known as mineral oil, is a highly refined liquid hydrocarbon. It acts as a lubricant and is poorly absorbed from the gastrointestinal tract. ## Primary Indications Constipation. ## Adult Dosing * **Oral:** 15-45 mL once daily, typically at bedtime. Doses can be adjusted based on patient response. * **Rectal (enema):** For rectal administration as an enema, follow institutional protocol or specific product labeling. ## Pediatric Dosing * **Oral (Aged 6 months to 12 years):** 5-15 mL once daily. Dosing should be individualized and used cautiously. Not recommended for infants under 6 months due to risk of aspiration and systemic absorption. * **Rectal (enema):** Follow institutional protocol or specific product labeling for pediatric enemas. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment, as systemic absorption is minimal. ## Contraindications * Hypersensitivity to liquid paraffin. * Concurrent use of cholecystography agents. * Patients with difficulty swallowing, nausea, vomiting, abdominal pain of unknown origin, or bowel obstruction. * Risk of aspiration, especially in the elderly, debilitated patients, or those with gastroesophageal reflux. ## Adverse Effects * **Common:** Anal leakage, abdominal cramping, bloating, diarrhea. * **Rare but Serious:** Lipoid pneumonia (if aspirated), vitamin malabsorption (with chronic use, particularly fat-soluble vitamins A, D, E, K). ## Key Drug Interactions * **Cholecystography Agents:** May interfere with imaging. Avoid concurrent administration. * **Fat-Soluble Vitamins (A, D, E, K):** Chronic oral use may impair absorption. Consider separate administration times or supplementation if chronic use is anticipated. * **Anionic Surfactants (e.g., docusate):** May reduce the efficacy of liquid paraffin when given concurrently. ## Monitoring * Monitor for bowel movements, consistency, and signs of fecal impaction or overflow diarrhea. * Assess for abdominal cramping, bloating, or anal leakage. * If used chronically, consider monitoring for signs of vitamin deficiency. ## Clinical Pearls * Administer at bedtime to minimize anal leakage and reduce the risk of aspiration during sleep. * Advise patients to remain upright for at least 2 hours after administration to reduce aspiration risk. * Due to the risk of aspiration, oral liquid paraffin should be used with extreme caution or avoided in individuals with impaired gag reflexes, dysphagia, or a history of aspiration. * Not intended for long-term use without medical supervision. *** *This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to determine the best course of treatment for your specific condition and to ensure you have the most up-to-date information. Always verify current prescribing information with the official product labeling.*